Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

248 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Assessment of NETest Clinical Utility in a U.S. Registry-Based Study.
Liu E, Paulson S, Gulati A, Freudman J, Grosh W, Kafer S, Wickremesinghe PC, Salem RR, Bodei L. Liu E, et al. Among authors: paulson s. Oncologist. 2019 Jun;24(6):783-790. doi: 10.1634/theoncologist.2017-0623. Epub 2018 Aug 29. Oncologist. 2019. PMID: 30158287 Free PMC article.
Time for a change and to adopt a novel molecular genomic approach in NETs.
Bodei L, Liu E, Paulson S, Gulati A, Freudman J, Grosh W, Kafer S, Wickremesinghe PC, Salem RR. Bodei L, et al. Among authors: paulson s. Nat Rev Clin Oncol. 2019 Apr;16(4):269-270. doi: 10.1038/s41571-019-0185-5. Nat Rev Clin Oncol. 2019. PMID: 30809030 No abstract available.
Early esophageal neuroendocrine tumor.
Branstetter H, Agarwal A, Paulson S, Nguyen AD, Konda V. Branstetter H, et al. Among authors: paulson s. Proc (Bayl Univ Med Cent). 2021 Aug 12;35(1):80-81. doi: 10.1080/08998280.2021.1955562. eCollection 2022. Proc (Bayl Univ Med Cent). 2021. PMID: 34970043 Free PMC article.
Neuroendocrine carcinoma of the prostate gland.
Hoof P, Tsai-Nguyen G, Paulson S, Syed A, Mora A Jr. Hoof P, et al. Among authors: paulson s. Proc (Bayl Univ Med Cent). 2016 Jan;29(1):68-9. doi: 10.1080/08998280.2016.11929365. Proc (Bayl Univ Med Cent). 2016. PMID: 26722176 Free PMC article.
Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 study.
Pant S, Schuler M, Iyer G, Witt O, Doi T, Qin S, Tabernero J, Reardon DA, Massard C, Minchom A, Lugowska I, Carranza O, Arnold D, Gutierrez M, Winter H, Stuyckens K, Crow L, Najmi S, Hammond C, Thomas S, Santiago-Walker A, Triantos S, Sweiti H, Loriot Y; RAGNAR Investigators. Pant S, et al. Lancet Oncol. 2023 Aug;24(8):925-935. doi: 10.1016/S1470-2045(23)00275-9. Lancet Oncol. 2023. PMID: 37541273 Clinical Trial.
Cabozantinib plus atezolizumab in previously untreated advanced hepatocellular carcinoma and previously treated gastric cancer and gastroesophageal junction adenocarcinoma: results from two expansion cohorts of a multicentre, open-label, phase 1b trial (COSMIC-021).
Li D, Loriot Y, Burgoyne AM, Cleary JM, Santoro A, Lin D, Aix SP, Garrido-Laguna I, Sudhagoni R, Guo X, Andrianova S, Paulson S. Li D, et al. Among authors: paulson s. EClinicalMedicine. 2023 Dec 21;67:102376. doi: 10.1016/j.eclinm.2023.102376. eCollection 2024 Jan. EClinicalMedicine. 2023. PMID: 38204489 Free PMC article.
248 results